In stratified analysis, patients with a diagnosis of ‘other psychoses’ and prescribed P-glycoprotein-inhibiting statins and initiating antipsychotics with affinity for P-glycoprotein also had lower rates of psychiatric admissions at 12 months than those initiating quetiapine. This evidence concerns the gene ABCB1 and nephrotic syndrome.